Stock Screener App

無料 - Play StoreApp Store

インストールインストール

NBTX

$29.613.68%1.05

Nanobiotix Adr (NBTX)

Date: O: H: L: C: Vol:

Nanobiotix Adr (NBTX) 最新ニュース

NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de deuxième ligne ou plus - GlobeNewswire Inc.

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma - GlobeNewswire Inc.

Nanobiotix (NBTX) Shares Gain 7.00% to $25.83, Pressing Toward $27.12 Resistance - Volatility Smile - https://www.dars.gov.et/

Nanobiotix (NBTX) Slips 1.03% to $21.08 as Shares Test Lower Support Zone - Flat Correction - siam.in

NBTX Stock Price, Quote & News - Syfe

DBV Technologies S.A. (DBV.PA) Stock Price, News, Quote & History - Yahoo! Finance Canada

NBTX Q2 2026 Earnings: Loss Per ADS Widens Far Beyond Consensus - Earnings Cycle Outlook - https://www.dars.gov.et/

NBTX Q2 2026 Earnings: Wider-Than-Expected Loss Overshadows Modest Share Gain - Capex Guidance - dars.gov.et

NBTX Q2 2026 Earnings: Wider-Than-Expected Loss Overshadows Modest Share Gain - Short-Term Outlook - https://www.dars.gov.et/

NBTX Q2 2026 Earnings: Loss Per Share Far Wider Than Expected as Revenue Stays Unreported - Management Guidance Update - https://www.dars.gov.et/

NBTX Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 7.71% - Earnings Volatility Report - https://www.dars.gov.et/

Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care - GlobeNewswire Inc.

NBTX Edges Lower: Nanobiotix Holds Near $33 as Traders Eye $31.64 Support - Relative Volume - https://www.siam.in/

NBTX Edges Lower: Nanobiotix Holds Near $33 as Traders Eye $31.64 Support - Triangle Correction - dars.gov.et

NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus Estimate - Annual Earnings Summary - www.dars.gov.et

NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus Estimate - Pre-Announcement Alert - www.dars.gov.et

NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus Estimate - Revenue Miss Report - dars.gov.et

NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus Estimate - Annual Financial Report - dars.gov.et

Stevanato Group S.p.A. (STVN) Stock Price & News - Syfe

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday - Benzinga

NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17% - Buyback Announcement Report - dars.gov.et

NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17% - Subscription Growth Report - careplusvn.com

NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17% - Positive Surprise Momentum - www.dars.gov.et

Biophytis (BPTS) Peer Comparison – Compare with Others - valueresearchonline.com

Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30% - Earnings Whisper Number - careplusvn.com

Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30% - Growth Acceleration Report - dars.gov.et

Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30% - Final Results - www.dars.gov.et

Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30% - Healthcare Earnings Report - dars.gov.et

Nanobiotix (NBTX) Q4 2025 Filing Snapshot: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings Trading: The Stock Records a 3.23% Decrease - Downward Estimate Revision - dars.gov.et

Nanobiotix (NBTX) Q4 2025 Filing Snapshot: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings Trading: The Stock Records a 3.23% Decrease - Financial Data - www.dars.gov.et

NBTX Q4 2025 Earnings: Clinical-Stage Burn and a Wide EPS Miss - ROE Trend Analysis - careplusvn.com

NBTX Q4 2025 Earnings: Clinical-Stage Burn and a Wide EPS Miss - Subscription Growth Report - dars.gov.et

Nanobiotix (NASDAQ:NBTX) Sees Large Volume Increase - Time to Buy? - MarketBeat

Nanobiotix S.A. (NBTX) investor group reports 9.4% stake and pre-funded warrants - Stock Titan

Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws Interest - Force Index - dars.gov.et

Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws Interest - Median Line - dars.gov.et

Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws Interest - Swing Trade Setups - www.dars.gov.et

Nanobiotix (NASDAQ:NBTX) Shares Gap Up - Here's What Happened - MarketBeat

Nanobiotix (NBTX) Q4 2025 Earnings: Missed EPS Estimate by Wide Margin as Stock Slips - Consensus Beat Rate - careplusvn.com

Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Nanobiotix (NBTX) Q4 2025 Earnings: Missed EPS Estimate by Wide Margin as Stock Slips - Mid-Term Outlook - dars.gov.et

Qatar Investment Authority (NBTX) reports 3.53M Nanobiotix ADRs under sole control - Stock Titan

Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.4% - What's Next? - MarketBeat

Nanobiotix (NBTX) Faces Selling Pressure: Approaching Key Support After 4% Decline - VWAP Bounce - careplusvn.com

Nanobiotix (NBTX) Faces Selling Pressure: Approaching Key Support After 4% Decline - FRAMA Signal - dars.gov.et

SK hynix Inc. American Depositary Shares (SKHY) Historical Data - Nasdaq

NBTX - Nanobiotix ADR Dividends - Finviz

5NRA Forecast — Price Target — Prediction for 2027 - TradingView

5NRA Forecast — Price Target — Prediction for 2027 - TradingView

NBTX Stock Price, Quote & Chart - ChartMill

NBTXに類似

QURE$21.798.71%

IMCR$29.491.80%

INVA$21.362.05%

URGN$29.9412.98%

TYRA$21.240.63%